Hi,

When a nerve is demyelinated enough, the axon gets cut. Is this right? Is this what brain atrophy is, or is that something else? Is it possible for the axons to get cut without having brain atrophy?

Laughter knocks MS backwards. You gottit here....

http://www.btinternet.com/~squiffyshouseoffun/

:D

Hi - I have been diagnosed with PPMS since 9/01 and I am partcipating in the Olympus Study: http://www.msstudy.net It is for PPMS. It is a double blind study measuring the safety and efficacy of rituximab compared with placebo in adult subjects with primary progressive multiple sclerosis (PPMS).

I have had 2 doses so far since 9/2004. The study will last 2.5 years. So far, I feel fine. I ...

With all this talk of Tysbrai and its high costs ( our nuero said about $26.000 a year) is anyone else worried about insurance and lifetime medical caps???

Somewhere in my research I found a site where someone had put together an information packet about LDN you could print out to show your MD. It looked like there was a lot of good info there.
I can't seem to locate it again. Anyone know what I'm talking about or where to find it?

I wish someone could explain to me why it is that the medical industry is so engrossed with treating ailments instead of doing things to make a patient healthier. The current approach that healthcare provides, when it’s at its very best, relies on fractured logic. Maybe it’s because desperate patients are willing to try anything that’s easy to rid themselves of disease. This leads to the other confusing logic I’ve encountered in the MS community. ...

Antisense Therapeutics Limited and Isis Pharmaceuticals Initiate Phase 2a Trial of Antisense Drug for Multiple Sclerosis
Tuesday December 21, 7:55 am ET

PRNewswire-FirstCall - Antisense Therapeutics Limited and Isis Pharmaceuticals announced today the initiation of a Phase 2a clinical trial of ATL1102 in patients with multiple sclerosis (MS).

ATL1102 is a second-generation antisense inhibitor of an immune system protein called VLA-4 (alpha-4 integrin chain; CD49d). ATL1102 is designed to block the synthesis of VLA-4 which ...

21 December 2004

Biogen Idec and Elan Announce Head-to-Head Study Comparing Safety and Efficacy of TYSABRI® to Rebif®
Zug, Switzerland – December 21, 2004 – Biogen Idec and Elan announced today that they are initiating a head-to-head study comparing the safety and efficacy of TYSABRI® (natalizumab) to Rebif® (Interferon beta-1a)*. STARS (Study of TYSABRI Against Rebif in relapsing multiple Sclerosis), is a randomized, assessor-blinded, parallel group study that will enroll more than 1,000 multiple sclerosis ...

As LDN increases the levels of endorphins, which are supposed to play a role in its efficacy... has anyone tried the alternative of increasing endorphins via excercise? Surely this would do the same things as endorphins are released during physical activity